## Abstract A phase II trial of etoposide and cisplatin for patients with previously treated small cell lung cancer was carried out by CALGB from June 1983 to May 1984. Thirtyโfive evaluable patients who had failed one prior chemotherapy regimen were treated with etoposide 80 mg/m^2^ and cisplatin
Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase II study of cancer and leukemia group B
โ Scribed by N.C. Choi; K. Propert; R. Carey; W. Eaton; L.A. Leone; P. Silberfarb; M. Green
- Publisher
- Elsevier Science
- Year
- 1987
- Tongue
- English
- Weight
- 918 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The Cancer and Leukemia Group B (CALGB) utilized a randomized phase II trial design to evaluate two cisplatinโbased combinations, cisplatinโcytarabine (araโC) and cisplatinโvinblastine, in 151 patients with advanced nonโsmall cell lung cancer. Patients entered on study had not received
## BACKGROUND. Both locoregional and distant disease control remains poor in the treatment of Stage III nonsmall cell lung carcinoma (NSCLC). This trial was conducted to evaluate the tolerance and responses of patients with NSCLC given a neoadjuvant regimen of cisplatin and vinorelbine chemotherapy